Enhanced Recovery After Surgery for Ovarian Cancer Patients
In this interview we discuss the idea behind an enhanced recovery program for patients undergoing cytoreductive surgery for ovarian cancer, as well as some of the potential cost savings.
Cancer Treatment for LGBTQ Patients
In this interview we discuss the approach to treating cancer in lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients.
Emerging Therapies in Multiple Myeloma
In this interview we discuss the latest therapy developments in the treatment of multiple myeloma.
Overview of Myeloproliferative Disorders
In this interview we discuss clinical developments in essential thrombocythemia, polycythemia vera, and myelofibrosis, as well as the latest treatment options.
Active Surveillance in Small Renal Masses
In this interview we discuss a new study that looked at the outcomes of patients with small renal masses who were followed with active surveillance.
Younger Thyroid Cancer Survivors at Higher Risk for Late Effects
In this interview we discuss a study that found that survivors of thyroid cancer diagnosed with the disease at a young age had an increased risk of late effects from therapy.
Latest Progress in Treating Urothelial Carcinoma
In this interview we discuss the latest clinical news in urothelial carcinoma, what we’ve learned about the biology of these tumors, and how treatment of this disease has evolved.
Treating Triple-Negative Breast Cancer
This slide deck covers the treatment of triple-negative breast cancer, a heterogeneous disease made up of numerous subtypes, and includes clinical variables that can help with prognosis and guide in treatment choice.
By clicking Accept, you agree to become a member of the UBM Medica Community.